CD163+ macrophages monitor enhanced permeability at the blood–dorsal root ganglion barrier
In dorsal root ganglia (DRG), macrophages reside close to sensory neurons and have largely been explored in the context of pain, nerve injury, and repair. However, we discovered that most DRG macrophages interact with and monitor the vasculature by sampling macromolecules from the blood. Characteriz...
Saved in:
Published in | The Journal of experimental medicine Vol. 221; no. 2 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Rockefeller University Press
05.02.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In dorsal root ganglia (DRG), macrophages reside close to sensory neurons and have largely been explored in the context of pain, nerve injury, and repair. However, we discovered that most DRG macrophages interact with and monitor the vasculature by sampling macromolecules from the blood. Characterization of the DRG vasculature revealed a specialized endothelial bed that transformed in molecular, structural, and permeability properties along the arteriovenous axis and was covered by macrophage-interacting pericytes and fibroblasts. Macrophage phagocytosis spatially aligned with peak endothelial permeability, a process regulated by enhanced caveolar transcytosis in endothelial cells. Profiling the DRG immune landscape revealed two subsets of perivascular macrophages with distinct transcriptome, turnover, and function. CD163+ macrophages self-maintained locally, specifically participated in vasculature monitoring, displayed distinct responses during peripheral inflammation, and were conserved in mouse and man. Our work provides a molecular explanation for the permeability of the blood–DRG barrier and identifies an unappreciated role of macrophages as integral components of the DRG-neurovascular unit. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 J. Han’s current affiliation is the Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. H. Lund, M.A. Hunt, and Z. Kurtović contributed equally to this paper. Disclosures: Z. Kurtović reported “other” from Kancera AB (PhD salary) during the conduct of the study. J.H. Graversen reported being a minor shareholder of OncoSpear ApS that develops CD163 antibodies for the treatment of cancer. No other disclosures were reported. |
ISSN: | 0022-1007 1540-9538 1540-9538 |
DOI: | 10.1084/jem.20230675 |